JP2023548711A5 - - Google Patents

Info

Publication number
JP2023548711A5
JP2023548711A5 JP2023527995A JP2023527995A JP2023548711A5 JP 2023548711 A5 JP2023548711 A5 JP 2023548711A5 JP 2023527995 A JP2023527995 A JP 2023527995A JP 2023527995 A JP2023527995 A JP 2023527995A JP 2023548711 A5 JP2023548711 A5 JP 2023548711A5
Authority
JP
Japan
Prior art keywords
minutes
delayed
softgel capsule
capsule according
shell composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023527995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023548711A (ja
JP7830457B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/072326 external-priority patent/WO2022104339A1/en
Publication of JP2023548711A publication Critical patent/JP2023548711A/ja
Publication of JP2023548711A5 publication Critical patent/JP2023548711A5/ja
Application granted granted Critical
Publication of JP7830457B2 publication Critical patent/JP7830457B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023527995A 2020-11-11 2021-11-10 遅延放出ソフトゲルカプセル Active JP7830457B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063112453P 2020-11-11 2020-11-11
US63/112,453 2020-11-11
PCT/US2021/072326 WO2022104339A1 (en) 2020-11-11 2021-11-10 Delayed release softgel capsules

Publications (3)

Publication Number Publication Date
JP2023548711A JP2023548711A (ja) 2023-11-20
JP2023548711A5 true JP2023548711A5 (enExample) 2024-11-13
JP7830457B2 JP7830457B2 (ja) 2026-03-16

Family

ID=81601948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023527995A Active JP7830457B2 (ja) 2020-11-11 2021-11-10 遅延放出ソフトゲルカプセル

Country Status (13)

Country Link
US (1) US20230404926A1 (enExample)
EP (1) EP4243772A4 (enExample)
JP (1) JP7830457B2 (enExample)
KR (1) KR20230106642A (enExample)
CN (1) CN116648238A (enExample)
AR (1) AR124043A1 (enExample)
AU (1) AU2021379780A1 (enExample)
CA (1) CA3197522A1 (enExample)
CO (1) CO2023007162A2 (enExample)
IL (1) IL302753A (enExample)
MX (1) MX2023005451A (enExample)
TW (1) TW202233164A (enExample)
WO (1) WO2022104339A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12440517B2 (en) 2022-09-29 2025-10-14 Oystershell Nv Soft gummy
BE1030925B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy
BE1030928B1 (nl) * 2022-09-29 2024-04-29 Oystershell Nv Zachte gummy
WO2024068994A1 (en) * 2022-09-29 2024-04-04 Oystershell Nv Soft gummy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944096B2 (ja) * 1979-12-24 1984-10-26 森下仁丹株式会社 親水性物質を充填物とするゼラチンカプセルの製造方法
AU2013200828A1 (en) * 2002-12-18 2013-03-07 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
CA2960631C (en) * 2014-10-06 2018-06-05 Fuji Capsule Co., Ltd. Method of manufacturing enteric soft capsule
WO2018035356A1 (en) * 2016-08-17 2018-02-22 Eupraxia Pharmaceuticals Inc. Sustained local delivery of drugs including antibiotics
WO2020247352A1 (en) * 2019-06-03 2020-12-10 R.P. Scherer Technologies, Llc Delayed release softgel capsules
US20220400724A1 (en) * 2019-10-28 2022-12-22 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment

Similar Documents

Publication Publication Date Title
JP2023548711A5 (enExample)
JP2023549177A5 (enExample)
JP2022535539A5 (enExample)
JP3822810B2 (ja) カプセルの密封方法
US20100297226A1 (en) Multiple unit pharmaceutical formulation
IL292583B1 (en) Delayed release softgel capsules in higher ph environment
JP2016006108A5 (enExample)
NO304406B1 (no) Preparat med regulert frigivelse og kapsel omfattende dette
JP2022554247A5 (enExample)
JP2004505918A5 (enExample)
JP2008540649A5 (enExample)
JPH064531B2 (ja) 大腸崩壊性硬質カプセル
JP2009514845A (ja) 味マスキング用多層コーティング技術
NO170912B (no) Fremgangsmaate for fremstilling av en fast, holdbar administreringsform
JP2022552223A5 (enExample)
JP2024525543A5 (enExample)
CN101861138A (zh) 控释的阿奇霉素固体剂型
JPH0692849A (ja) フラン誘導体を含有する医薬組成物
BRPI0615014A2 (pt) composição farmacêutica sólida compreendendo 1-(4-cloroanilino)-4-(4-piridilmetil)ftalazina e um modificador de ph e uso da mesma
JP2023532180A5 (enExample)
CN103933009B (zh) 用于制备纤维素硬胶囊的组合物及其应用
WO2009014372A2 (en) Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof
JP2023547062A5 (enExample)
JP2025508321A5 (enExample)
JP2009519313A5 (enExample)